Jasin (2013): Nonsurgical Rhinoplasty Using Dermal Fillers
M.E. Jasin · Facial Plastic Surgery Clinics of North America, 2013PMID: 23731585
Supports: Review outlining nonsurgical rhinoplasty as a viable alternative to surgery using newer injectable fillers with less immunogenicity and greater longevity. Covers surgical anatomy relevant to injection planning, filler selection properties, treatable nasal deformities (dorsal humps, tip ptosis, contour irregularities), and the role of injectables in post-rhinoplasty correction.
Limitations: Narrative review, not a clinical trial. No quantitative efficacy or safety data. Published 2013; filler technology and techniques have advanced since.
View on PubMed →DeVictor, Ong & Sherris (2021): Complications Secondary to Nonsurgical Rhinoplasty — A Systematic Review and Meta-Analysis
S. DeVictor, A.A. Ong, D.A. Sherris · Otolaryngology—Head and Neck Surgery, 2021PMID: 33588622
Supports: Meta-analysis of 37 publications (23 cohort studies, 14 case reports, 8,604 patients). Overall adverse outcome rate 2.52%. Most common: bruising (1.58%), hematoma (0.13%). Major complications rare: vessel occlusion (0.35%), vision loss (0.09%), skin necrosis (0.08%), infection (0.07%). Confirms nonsurgical rhinoplasty with injectable fillers is safe overall.
Limitations: Includes case reports alongside cohort studies. Further studies needed to optimise filler delivery techniques to decrease adverse outcome rates.
View on PubMed →Kumar et al. (2021): Non-Surgical Rhinoplasty Using Hyaluronic Acid Dermal Fillers — A Systematic Review
V. Kumar, A. Jain, S. Atre, D. Shome, R. Kapoor, K. Doshi, S. Vadera · Journal of Cosmetic Dermatology, 2021PMID: 33900020
Supports: Systematic review of 11 studies (2,896 citations screened, 2005-2021) showing average patient satisfaction >90% for non-surgical rhinoplasty with HA fillers. Confirms it as a good, minimally invasive alternative to conventional rhinoplasty. Temporary complications: transient oedema, erythema, post-injection pain, bruising. Rare: vascular impairment, haematoma.
Limitations: Paucity of quality experimental and prospective data. Heterogeneous study designs and outcome measures across included studies.
View on PubMed →Jalali (2024): Nonsurgical Rhinoplasty Using the HA Filler VYC-25L — Safety and Patient Satisfaction in 492 Patients
A. Jalali · Journal of Cosmetic Dermatology, 2024PMID: 37740484
Supports: Retrospective analysis of 492 consecutive patients (984 sessions, mean follow-up 11.1 months). FACE-Q scores: 90.2% Satisfaction with Nose, 99.2% Satisfaction with Outcome. No cases of necrosis, blindness, lumps, granuloma, or delayed-onset nodules. Vascular occlusion (0.6%) resolved with hyaluronidase.
Limitations: Retrospective single-injector study. Single filler product (VYC-25L/Vycross). Bruising in 25% and residual asymmetry in 3.7% of patients.
View on PubMed →*PRP London Clinic provides these references for educational purposes. Our Clinical Board regularly reviews emerging peer-reviewed literature to ensure our protocols align with the latest advancements in regenerative medicine.